Skip to main content

Want a detailed portfolio tracker?

Clearside Biomedical, Inc. Common Stock (CLSD) Operating Margin (2016 - 2025)

Clearside Biomedical, Inc. Common Stock (CLSD) operating margin from Jun 30, 2016 to Sep 30, 2025. The current Clearside Biomedical, Inc. Common Stock (CLSD) operating margin is -1735.00%. You can export chart.

Annual Operating Margin

Quarterly Operating Margin

Annual Operating Margin change of Clearside Biomedical, Inc. Common Stock (CLSD)

YearOperating MarginChange
2024-1739.76%
+476.42%
2023-301.82%
-86.74%
2022-2276.69%
+106796.10%
2021-2.13%
-99.06%
2020-227.25%
-83.73%
2019-1396.31%
-99.49%
2018-276466.67%
+1556.62%
2017-16688.57%
+244.37%
2016-4846.15%
N/A

Comparison Clearside Biomedical, Inc. Common Stock (CLSD) operating margin with competitors

Clearside Biomedical, Inc. Common Stock (CLSD) operating margin is -1735.00%.

TickerNameOperating MarginUpside
VIRVir Biotechnology Inc459241.00%-26569.22%
APLMApollomics Inc - Class A431.90%-124.89%
ABUSArbutus Biopharma Corp94.30%-105.44%
SAVACassava Sciences Inc.93.36%-105.38%
RPRXRoyalty Pharma plc - Class A89.29%-105.15%
GLPGGalapagos NV84.24%-104.86%
NEUPNeuphoria Therapeutics Inc79.85%-104.60%
BDTXBlack Diamond Therapeutics Inc77.90%-104.49%
CTNMContineum Therapeutics Inc - Class A77.87%-104.49%
CVACCureVac N.V.74.59%-104.30%
IPSCCentury Therapeutics Inc67.95%-103.92%
FULCFulcrum Therapeutics Inc65.62%-103.78%
AVIRAtea Pharmaceuticals Inc63.06%-103.63%
PLXProtalix BioTherapeutics Inc62.65%-103.61%
PRTAProthena Corporation plc58.80%-103.39%
AUPHAurinia Pharmaceuticals Inc53.31%-103.07%
ADMAAdma Biologics Inc50.90%-102.93%
RPTXRepare Therapeutics Inc50.85%-102.93%
CRMDCorMedix Inc49.96%-102.88%
HCWBHCW Biologics Inc49.45%-102.85%
CPRXCatalyst Pharmaceuticals Inc49.02%-102.83%
SRPTSarepta Therapeutics Inc49.00%-102.82%
HALOHalozyme Therapeutics Inc48.98%-102.82%
KRYSKrystal Biotech Inc46.14%-102.66%
AGENAgenus Inc44.62%-102.57%
CGENCompugen Ltd43.05%-102.48%
SVASinovac Biotech Ltd42.30%-102.44%
EXELExelixis Inc41.15%-102.37%
QTTBQ32 Bio Inc39.80%-102.29%
INVAInnoviva Inc38.94%-102.24%
VRTXVertex Pharmaceuticals Inc38.10%-102.20%
NXTCNextcure Inc36.70%-102.12%
LGNDLigand Pharmaceuticals Inc - Class B33.58%-101.94%
SLNOSoleno Therapeutics Inc33.06%-101.91%
JAZZJazz Pharmaceuticals plc31.49%-101.81%
ARGXArgen X SE30.35%-101.75%
CAICaris Life Sciences Inc - Class A30.19%-101.74%
TNGXTango Therapeutics Inc26.15%-101.51%
GMABGenmab25.11%-101.45%
ZVRAZevra Therapeutics Inc24.40%-101.41%
TECHBio-Techne Corp24.24%-101.40%
INCYIncyte Corp23.66%-101.36%
RIGLRigel Pharmaceuticals20.21%-101.16%
ICCCImmucell Corp19.01%-101.10%
REGNRegeneron Pharmaceuticals Inc17.83%-101.03%
NERVMinerva Neurosciences Inc17.73%-101.02%
HRMYHarmony Biosciences Holdings Inc17.31%-101.00%
TGTXTG Therapeutics Inc16.98%-100.98%
BMRNBiomarin Pharmaceutical Inc16.92%-100.98%
ONCBeiGene Ltd16.51%-100.95%
PTCTPTC Therapeutics Inc16.50%-100.95%
PHARPharming Group N.V.16.26%-100.94%
ENVBEnveric Biosciences Inc13.38%-100.77%
VXRTVaxart Inc13.19%-100.76%
VRNAVerona Pharma Plc12.90%-100.74%
ALNYAlnylam Pharmaceuticals Inc12.01%-100.69%
ASNDAscendis Pharma A/S10.06%-100.58%
APLSApellis Pharmaceuticals Inc9.86%-100.57%
FOLDAmicus Therapeutics Inc8.61%-100.50%
CGEMCullinan Oncology Inc7.24%-100.42%
IMCRImmunocore Holdings plc6.82%-100.39%
NAGENiagen Bioscience Inc5.01%-100.29%
NUVBNuvation Bio Inc - Class A4.66%-100.27%
BMEABiomea Fusion Inc2.46%-100.14%
TLXTelix Pharmaceuticals Ltd1.58%-100.09%
HOTHHoth Therapeutics Inc0.17%-100.01%
BBLGBone Biologics Corp0.04%-100.00%